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Flow perfusion culture is used in many areas of tissue engineering and offers several key advantages. However,
one challenge to these cultures is the relatively low-throughput nature of perfusion bioreactors. Here, a flow
perfusion bioreactor with increased throughput was designed and built for tissue engineering. This design uses
an integrated medium reservoir and flow chamber in order to increase the throughput, limit the volume of
medium required to operate the system, and simplify the assembly and operation.
Overview of Flow Perfusion Bioreactors
Flow perfusion bioreactors are commonly used inmany areas of tissue engineering.1–5 Such systems are
designed to perfuse culture medium through the inter-
connected pores of a tissue culture scaffold. This method of
culture has two primary advantages. Perfusion culture can
be used to increase the rates of mass transport through the
interior of the scaffold compared with the rate of diffusion
alone6 and can be used to apply mechanical stimulation, in
the form of shear stress, to cells in the scaffold, in order to
achieve a desired cellular response.6,7
There are ubiquitous challenges encountered with perfu-
sion bioreactors, and their use with specific tissues, such as
cartilage, often presents several additional unique chal-
lenges. One of the primary limitations to perfusion cultures is
the relatively low-throughput nature of these systems. This is
primarily due to space limitations, as perfusion bioreactors
require relatively large amounts of space to operate in a
controlled environment. However, the time intensive as-
sembly and operation can further limit output. Chondro-
genic cultures often necessitate the use of growth factors, and
with the large volumes of culture medium that are often
necessary to operate perfusion bioreactors, incorporating
growth factors into the culture medium can be costly. Ad-
ditionally, the rabbit osteochondral defect model is one of the
most widely used animal models in articular cartilage engi-
neering.8 Here, the critical-sized defect is 3mm in diameter.8
Thus, the ideal perfusion bioreactor for cartilage engineering
would be capable of culturing scaffolds of this size but be
easily adaptable to other scaffold sizes.
The objective of this work was to design a flow perfusion
bioreactor for tissue engineering, while addressing some of
the challenges encountered with perfusion bioreactors, pri-
marily the low-throughput nature. Additionally, due to our
interest in cartilage engineering, the design considered the
earlier-mentioned challenges specific to this field. The primary
design requirement of the system was the ability to provide
a consistent and controllable media flow rate through the
scaffolds. Additionally, the design was intended to allow for
high-throughput cultures, while minimizing the volume of
medium required to operate the system. The bioreactor was
designed to initially culture scaffolds of 3mm in diameter but
to be easily adaptable to additional scaffold sizes. Ad-
ditionally, the system was designed to eliminate air bubbles
before reaching the scaffolds in order to not disrupt the cul-
tures. Finally, all parts were designed to be autoclavable and
easily handled and assembled under sterile conditions.
Design Philosophy
In many perfusion bioreactor designs, the medium is
contained within reservoirs, separate from the flow chamber
where the scaffolds are perfused.6 Here, by integrating the
medium reservoir and flow chamber into one unit, the
amount of medium and tubing and the number of parts re-
quired to run the system are significantly reduced. In com-
bination with perfusing the scaffolds from top to bottom, the
air bubbles are prevented from accumulating below the
scaffolds and are eliminated before reaching the scaffolds and
disturbing the culture. Finally, culturing multiple scaffolds
per flow channel provides significant flexibility when select-
ing a volumetric flow rate, as the culture medium is divided
between multiple samples as the scaffolds are perfused.
Design
The bioreactor design, shown in Figure 1, consists of four
main components. The scaffold holder, medium reservoir,
and peristaltic pump and tubing.
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Scaffold holder
Scaffolds are contained within custom-made, auto-
clavable, polycarbonate scaffold holders, shown in Figure 2.
Each scaffold holder is desiged to contain 10 scaffolds 3mm
in diameter, distributed axisymmetrically in order to ensure
an equal division of flow through the scaffolds. This scaffold
holder can be easily adapted to fit other scaffold sizes, as
shown in Figure 3. Samples are pressfit from the bottom of
the holder and supported from below by a stainless steel 316
mesh (McMaster-Carr, Elmhurst, IL). The support mesh
slides into place and is held by two tabs on the bottom of the
scaffold holder. The thickness of the scaffold holder was
chosen so that each individual flow channel in the holder is
able to contain an appropriate volume of cell solution for
seeding scaffolds. This dimension (11.5mm) is significantly
more than the entrance length required for fully developed
flow at the scaffold surface,9 which is necessary to minimize
entrance effects.
Medium reservoir lid and base
The medium reservoir consists of two pieces machined
from stainless steel 316. The two pieces fit together to form a
base and lid. The scaffold holder is placed in between the
two pieces with nitrile rubber o-rings (McMaster-Carr) on
top and bottom. The medium reservoir is compressed to-
gether and held with stainless steel bolts and wingnuts.
Medium is contained both above and below the scaffolds,
with*25mL contained below the scaffolds. The system can
operate with as little as 10mL in the reservoir above the
scaffolds, but can store as much as 120mL, bringing the total
medium volume range in the system to 35 to 145mL.
Medium is changed through a port of the lid that can be
sealed by a silicone rubber stopper (McMaster-Carr). Two
additional ports lead to two polypropylene, barbed, male
threaded adapters (Cole Parmer, Vernon Hills, IL). One
adapter leads to a syringe filter that faciliates gas exchange,
and the other adapter connects to the inlet tubing. The
reservoir base contains an adapter that leads to the outlet
tubing.
Peristaltic pump and tubing
The inlet and outlet tubing is made of platinum-cured
silicone (Masterflex tubing; Cole Parmer). Platinum-cured
tubing is used to reduce the amount of leachable chemicals
and is relatively low-protein binding. Further, the tubing is
gas permeable to oxygen and carbon dioxide. A short seg-
ment of mechanically stronger, neoprene, nongas-permeable
tubing is used within the pump (Pharmed tubing; Cole
Parmer). With the tubing size used in this system (Cole
FIG. 1. (A) Schematic of assembled bioreactor unit with the integrated medium reservoir and flow chamber. (B) Image of
assembled bioreactor unit.
FIG. 2. Scaffold holder and stainless steel 316 support
mesh. Ten scaffolds, 3mm in diameter, are distributed ax-
isymmetrically and pressfit into position. A support mesh
slides into place to prevent the movement of scaffolds during
culture.
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Parmer L/S 13) the pump is capable of accurately and con-
sistently pumping flow rates from 0.06 to 6.0mL/min
through each flow chamber. This flow rate is divided equally
between all scaffolds in one flow chamber. Each pump is
capable of driving 12 flow chambers, given that the pump is
a 12-channel peristaltic pump (Cole Parmer).
Representative Results
Scaffolds were fabricated by electrospinning poly
(e-caprolactone) meshes with an average fiber diameter of
10 mm using previously established methods.10 Scaffolds
3mm in diameter and 1.0–1.1-mm thick were die-punched
using a 3-mm dermal biopsy punch. Bovine chondrocytes
were isolated and pooled from the femoral condyle of
three 7–10-day-old calves (Research 87, Boylston, MA) using
established methods.11,12 Primary chondrocytes were seeded
at a density of 50,000 cells per scaffold and incubated over-
night. Cultures were then continued either in the flow per-
fusion bioreactor or under static conditions in a 24-well
culture plate. Perfusion cultures were performed with a flow
rate of 0.03mL/min through each scaffold. All constructs
were cultured in chondrocyte proliferation medium,11 which
consisted of Dulbecco’s modified Eagle’s medium, 10% fetal
bovine serum (Gemini Bio-Products, West Sacramento, CA),
1% nonessential amino acids, 0.4mM proline, 10mM HEPES
buffer, and 50mg/L ascorbic acid, and penicillin, strepto-
mycin, and fungizone. After 14 days, samples were removed
from culture, rinsed in phosphate-buffered saline, and fixed
with 10% neutral-buffered formalin (Fisher Scientific, Pitts-
burgh, PA). Samples were then soaked in 70% ethanol, em-
bedded in HistoPrep freezing medium (Fisher Scientific),
frozen at - 20C, and sectioned using a cryotome (Leica
Biosystems, Richmond, IL). Sections from each scaffold (n = 2
scaffolds per culture condition) were cut to a thickness of
5mm, mounted onto Superfrost Excell glass slides (Fisher
Scientific), and stained using Safranin O histological stain to
visualize the distribution of extracellular matrix. Images
were obtained using a light microscope (Zeiss Axio Imager 2;
Carl Zeiss, Oberkochen, Germany) with a video camera at-
tachment (Zeiss Axio Cam MRc5; Carl Zeiss). Representative
images are shown in Figure 4. In all scaffolds evaluated
there was a significant increase in chondrocyte extracellular
matrix in perfused scaffolds, compared with static. These
results demonstrate the significant enhancement that can be
seen with flow perfusion culture, consistent with previous
studies.9
Design Limitations
As with any bioreactor design, there are several limita-
tions to this system. To begin with, while culturing multiple
scaffolds per flow channel allows for high-throughput cul-
tures, all of the scaffolds within one flow chamber share a
FIG. 3. The scaffold holder is
easily adaptable to other
scaffold sizes and numbers.
Shown here from left to right
are scaffold holders designed
to support twenty 2-mm
scaffolds, ten 3-mm scaffolds,
ten 5-mm scaffolds, and four
8-mm scaffolds.
FIG. 4. Representative
histological sections of
electrospun poly(e-
caprolactone) scaffolds with
bovine chondrocytes cultured
for 14 days under (A) static
and (B) flow perfusion
conditions. Images show
histological sections stained
with Safranin O to visualize
cartilaginous matrix.
Extracellular matrix
proteoglycans are stained
red, and representative
examples are indicated
with yellow arrows.
Representative examples of
poly(e-caprolactone) fibers
are marked with blue arrows.
Scale bar represents 100 mm in
both images. These images
demonstrate the significant
increase in cartilage-like
matrix as a result of perfusion
culture.
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common medium reservoir and thus should be within the
same experimental group. Similarly, all of the samples in a
single scaffold holder must be harvested at the same time
point. However, multiple bioreactor units can be used to
incorporate additional groups and time points in one ex-
periment. Finally, the medium flow is divided between all
scaffolds in a flow chamber, so in order for the flow rate to be
evenly distributed between all scaffolds, the resistance of
each scaffold to fluid flow must be equal. Thus, each scaffold
must have relatively uniform interior geometries and ap-
proximately equal scaffold thicknesses. Further, if one or
more scaffolds were damaged or shifted during culture, the
flow rate through all scaffolds in the flow chamber would be
affected. However, scaffolds are both pressfit into the scaf-
fold holder and supported by the stainless steel mesh to
prevent such problems. Finally, with the integrated medium
reservoir and flow channel, portions of the culture medium
are contained both above and below the scaffolds. It is in-
tended that medium changes be performed from the port on
the top of the reservoir; however, *25mL of medium is
contained below the scaffold holder and cannot be changed
using this method, which could allow for the undesired ac-
cumulation of waste products. However, in some cases,
partial medium replacements could be advantagous as they
allow endogenous cytokines to remain in low levels.13 Fur-
ther, this limitation can be overcome by increasing the fre-
quency of medium changes or increasing the volume of
medium contained in the top region of the medium reservoir
(capable of holding 10 to 120mL) in order to reduce the
significance of the unchangable 25mL.
Conclusion
In conclusion, a flow perfusion bioreactor system has been
designed and built for high-throughput cultures. This system
contains an integrated medium reservoir and flow chamber
in order to reduce the number of parts and volume of me-
dium required. Additionally, multiple samples per flow
chamber allow for increased production capacity. Further,
this system is able to operate with a relatively low volume of
medium and has simplified assembly and operation.
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